TipRanks
Advertisement

SPSM - ETF AI Analysis

Compare

Top Page

SPSM

SPDR Portfolio S&P 600 Small Cap ETF (SPSM)

Rating:66Neutral
Price Target:
SPSM, the SPDR Portfolio S&P 600 Small Cap ETF, earns a solid overall rating driven mainly by strong contributors like Paycom and Corcept Therapeutics, which show robust financial performance, revenue growth, and supportive technical trends. Jackson Financial and Qorvo also add to the fund’s quality with good earnings and positive corporate developments, though several holdings such as ViaSat and Glaukos face profitability, leverage, and valuation challenges that modestly weigh on the ETF’s appeal. The main risk factor is its focus on small-cap stocks, which can bring higher volatility and sensitivity to financial and operational setbacks across individual companies.
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and over the past few months, showing solid recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors, including financials, industrials, technology, consumer cyclical, and health care, which helps reduce the impact of weakness in any single industry.
Very Low Expense Ratio
The fund charges a very low fee, which helps investors keep more of their returns over time.
Negative Factors
Heavy U.S. Concentration
Almost all of the ETF’s assets are invested in U.S. companies, offering little geographic diversification outside the United States.
Small-Cap Volatility Risk
Because the fund focuses on smaller companies, its share price can be more sensitive to market swings and economic slowdowns.
Sector Tilts Toward Financials and Industrials
Larger weights in financial and industrial stocks mean the fund could be more affected if these sectors face a downturn.

SPSM vs. SPDR S&P 500 ETF (SPY)

SPSM Summary

SPSM is the SPDR Portfolio S&P 600 Small Cap ETF, which follows the S&P SmallCap 600 Index. It invests in hundreds of smaller U.S. companies across many sectors, including financials, industrials, technology, and health care. Some of its well-known holdings include Match Group and Molina Healthcare. Investors might consider SPSM if they want broad diversification into small U.S. companies that could have higher growth potential than large, established firms. However, small-cap stocks can be more volatile than larger companies, so the value of this ETF can rise and fall more sharply with the market.
How much will it cost me?The SPDR Portfolio S&P 600 Small Cap ETF (SPSM) has an expense ratio of 0.03%, meaning you’ll pay $0.30 per year for every $1,000 invested. This is much lower than average because it’s a passively managed fund that tracks an index, which typically costs less to operate than actively managed funds.
What would affect this ETF?The SPSM ETF, which focuses on small-cap U.S. companies, could benefit from economic growth and innovation in sectors like technology and industrials, as these industries are among its largest exposures. However, small-cap stocks are often more sensitive to rising interest rates and economic slowdowns, which could negatively impact the ETF's performance. Regulatory changes or sector-specific challenges, such as shifts in healthcare policy or fluctuations in energy prices, may also influence its future returns.

SPSM Top 10 Holdings

SPSM is powered by a diverse cast of U.S. small caps, with health care names like Corcept Therapeutics and Protagonist Therapeutics rising strongly and giving the fund a growth-oriented feel. Consumer-facing stocks such as Brinker International and CarMax are also climbing, helping performance as diners and used-car buyers return, even if leverage and operational hiccups keep their stories a bit bumpy. Tech and communications exposure via Paycom and Match Group adds more momentum, while laggards like ViaSat and the steadier Ryman hospitality stake act as ballast rather than rocket fuel.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Corcept Therapeutics0.61%$98.10M$12.09B48.72%
76
Outperform
Match Group0.60%$96.02M$10.00B15.94%
66
Neutral
Glaukos0.58%$93.40M$9.64B99.11%
61
Neutral
Jackson Financial Incorporation0.55%$89.28M$9.29B41.65%
73
Outperform
ViaSat0.55%$88.78M$9.77B119.25%
56
Neutral
Qorvo0.54%$87.54M$10.05B30.00%
71
Outperform
Paycom0.54%$87.17M$10.08B5.99%
76
Outperform
SM Energy0.54%$87.14M$9.08B39.12%
72
Outperform
Brinker International0.50%$80.82M$8.80B45.88%
70
Neutral
Protagonist Therapeutics0.50%$80.29M$9.24B141.20%
68
Neutral

SPSM Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
56.70
Negative
100DMA
55.51
Negative
200DMA
52.29
Positive
Market Momentum
MACD
-0.65
Positive
RSI
31.74
Neutral
STOCH
14.25
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SPSM, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 56.01, equal to the 50-day MA of 56.70, and equal to the 200-day MA of 52.29, indicating a neutral trend. The MACD of -0.65 indicates Positive momentum. The RSI at 31.74 is Neutral, neither overbought nor oversold. The STOCH value of 14.25 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SPSM.

SPSM Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$16.07B0.03%
66
Neutral
$107.09B0.06%
65
Neutral
$79.08B0.03%
66
Neutral
$77.81B0.19%
63
Neutral
$22.03B0.03%
64
Neutral
$4.13B0.07%
66
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SPSM
SPDR Portfolio S&P 600 Small Cap ETF
54.45
8.51
18.52%
IJR
iShares Core S&P Small Cap ETF
VB
Vanguard Small-Cap ETF
IWM
iShares Russell 2000 ETF
SCHA
Schwab U.S. Small-Cap ETF
VIOO
Vanguard S&P Small-Cap 600 ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement